| 書名 | 作者 | 出版年 | 查看 | 回報錯誤連結 |
|---|
| Pharmacological CLASSIFICATION OF DRUGS with Doses and Preparations |
KD Tripathi. |
2010 |
查看
|
回報問題連結 |
| A handbook of bioanalysis and drug metabolism |
Gary Evans. |
2004 |
查看
|
回報問題連結 |
| Hygiene in der arzneimittelproduktion :Sterile und nicht-sterile Arzeneiformen / |
Michael Rieth und Norbert Krämer. |
|
查看
|
回報問題連結 |
| ICH quality guidelines:an implementation guide / |
Andrew Teasdale, David Elder, Raymond W. Nims. |
2018 |
查看
|
回報問題連結 |
| Peptidomimetics in organic and medicinal chemistry:the art of transforming peptides in drugs / |
Andrea Trabocchi and Antonio Guarna. |
2014 |
查看
|
回報問題連結 |
| Simulation for designing clinical trials:a pharmacokinetic-pharmacodynamic modeling perspective / |
[edited by] Hui C. Kimko, Stephen B. Duffull. |
2003 |
查看
|
回報問題連結 |
| Modern pharmaceutics |
Gilbert S. Banker, Christopher T. Rhodes. |
2002 |
查看
|
回報問題連結 |
| Microbiological contamination control in pharmaceutical clean rooms |
Nigel Halls. |
2004 |
查看
|
回報問題連結 |
| Pharmaceutical chemical analysis:methods for identification and limit tests / |
Ole Pedersen. |
2006 |
查看
|
回報問題連結 |
| Handbook of assay development in drug discovery |
Lisa K. Minor. |
2006 |
查看
|
回報問題連結 |
| Dose optimization in drug development |
Rajesh Krishna. |
2006 |
查看
|
回報問題連結 |
| Using mass spectrometry for drug metabolism studies |
Walter A. Korfmacher. |
2005 |
查看
|
回報問題連結 |
| Significant pharmaceuticals reported in recent US patents |
Thomas F. DeRosa. |
2007 |
查看
|
回報問題連結 |
| Patient safety informatics:adverse drug events, human factors, and IT tools for patient medication safety / |
Vassilis Koutkias ... [et al.]. |
2011 |
查看
|
回報問題連結 |
| Using mass spectrometry for drug metabolism studies |
Walter A. Korfmacher. |
2010 |
查看
|
回報問題連結 |
| Innovation in clinical trial methodologies:lessons learned during the Corona pandemic / |
Peter Schueler. |
2021 |
查看
|
回報問題連結 |
| Generic drug product development:specialty dosage forms / |
Leon Shargel, Isadore Kanfer. |
2010 |
查看
|
回報問題連結 |
| The therapeutic use of N-Acetylcysteine (NAC) in medicine / |
Richard Eugene Frye, Michael Berk. |
|
查看
|
回報問題連結 |
| Chirality in drug design and development |
Indra K. Reddy, Reza Mehvar. |
2004 |
查看
|
回報問題連結 |
| Prescribing guidelines |
David Taylor, Carol Paton, Shitij Kapur. |
2009 |
查看
|
回報問題連結 |
| Hit and lead profiling:identification and optimization of drug-like molecules / |
Bernard Faller and Laszlo Urban. |
2009 |
查看
|
回報問題連結 |
| Molecular docking for computer-aided drug design:fundamentals, techniques, resources and applications / |
Mohane S. Coumar. |
2021 |
查看
|
回報問題連結 |
| Peptide chemistry and drug design |
Ben M. Dunn. |
2015 |
查看
|
回報問題連結 |
| The prescription drug guide for nurses |
Sue Jordan. |
2008 |
查看
|
回報問題連結 |
| A practical guide to rational drug design |
Sun Hongmao. |
2015 |
查看
|
回報問題連結 |
|
|
